vs
杜比实验室（DLB）与LifeStance Health Group, Inc.（LFST）财务数据对比。点击上方公司名可切换其他公司
杜比实验室的季度营收约是LifeStance Health Group, Inc.的1.0倍（$395.6M vs $382.2M），杜比实验室净利率更高（24.0% vs 3.1%，领先20.9%），LifeStance Health Group, Inc.同比增速更快（17.4% vs 7.1%），过去两年杜比实验室的营收复合增速更高（13.9% vs 12.8%）
杜比实验室是一家美国科技企业，专注于音频降噪、音频编码压缩、空间音频及高动态范围（HDR）影像等技术的研发，旗下技术广泛授权给全球各地的消费电子制造商使用，助力终端产品为用户带来更出色的视听体验。
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
DLB vs LFST — 直观对比
营收规模更大
DLB
是对方的1.0倍
$382.2M
营收增速更快
LFST
高出10.4%
7.1%
净利率更高
DLB
高出20.9%
3.1%
两年增速更快
DLB
近两年复合增速
12.8%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $395.6M | $382.2M |
| 净利润 | $94.9M | $11.7M |
| 毛利率 | 88.7% | — |
| 营业利润率 | 28.5% | 4.7% |
| 净利率 | 24.0% | 3.1% |
| 营收同比 | 7.1% | 17.4% |
| 净利润同比 | 3.4% | 264.1% |
| 每股收益（稀释后） | $0.99 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DLBLFST
| Q2 26 | $395.6M | — | ||
| Q1 26 | $346.7M | — | ||
| Q4 25 | $346.7M | $382.2M | ||
| Q3 25 | $307.0M | $363.8M | ||
| Q2 25 | $315.5M | $345.3M | ||
| Q1 25 | $369.6M | $333.0M | ||
| Q4 24 | $357.0M | $325.5M | ||
| Q3 24 | $304.8M | $312.7M |
净利润DLBLFST
| Q2 26 | $94.9M | — | ||
| Q1 26 | $53.3M | — | ||
| Q4 25 | $53.3M | $11.7M | ||
| Q3 25 | $49.3M | $1.1M | ||
| Q2 25 | $46.1M | $-3.8M | ||
| Q1 25 | $91.8M | $709.0K | ||
| Q4 24 | $67.8M | $-7.1M | ||
| Q3 24 | $58.6M | $-6.0M |
毛利率DLBLFST
| Q2 26 | 88.7% | — | ||
| Q1 26 | 87.5% | — | ||
| Q4 25 | 87.5% | — | ||
| Q3 25 | 87.1% | — | ||
| Q2 25 | 86.1% | — | ||
| Q1 25 | 90.3% | — | ||
| Q4 24 | 88.6% | — | ||
| Q3 24 | 88.8% | — |
营业利润率DLBLFST
| Q2 26 | 28.5% | — | ||
| Q1 26 | 17.9% | — | ||
| Q4 25 | 17.9% | 4.7% | ||
| Q3 25 | 9.7% | 2.0% | ||
| Q2 25 | 15.1% | -0.9% | ||
| Q1 25 | 29.2% | 0.5% | ||
| Q4 24 | 22.4% | 0.3% | ||
| Q3 24 | 15.2% | 0.0% |
净利率DLBLFST
| Q2 26 | 24.0% | — | ||
| Q1 26 | 15.4% | — | ||
| Q4 25 | 15.4% | 3.1% | ||
| Q3 25 | 16.1% | 0.3% | ||
| Q2 25 | 14.6% | -1.1% | ||
| Q1 25 | 24.8% | 0.2% | ||
| Q4 24 | 19.0% | -2.2% | ||
| Q3 24 | 19.2% | -1.9% |
每股收益（稀释后）DLBLFST
| Q2 26 | $0.99 | — | ||
| Q1 26 | $0.55 | — | ||
| Q4 25 | $0.55 | — | ||
| Q3 25 | $0.50 | — | ||
| Q2 25 | $0.48 | — | ||
| Q1 25 | $0.94 | — | ||
| Q4 24 | $0.70 | — | ||
| Q3 24 | $0.59 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $594.7M | $248.6M |
| 总债务越低越好 | — | $282.8M |
| 股东权益账面价值 | $2.6B | $1.5B |
| 总资产 | $3.2B | $2.2B |
| 负债/权益比越低杠杆越低 | — | 0.19× |
8季度趋势，按日历期对齐
现金及短期投资DLBLFST
| Q2 26 | $594.7M | — | ||
| Q1 26 | $644.6M | — | ||
| Q4 25 | $644.6M | $248.6M | ||
| Q3 25 | $702.6M | $203.9M | ||
| Q2 25 | $699.3M | $188.9M | ||
| Q1 25 | $626.6M | $134.3M | ||
| Q4 24 | $520.8M | $154.6M | ||
| Q3 24 | $482.0M | $102.6M |
总债务DLBLFST
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $282.8M | ||
| Q3 25 | — | $284.6M | ||
| Q2 25 | — | $286.4M | ||
| Q1 25 | — | $288.2M | ||
| Q4 24 | — | $290.0M | ||
| Q3 24 | — | $287.3M |
股东权益DLBLFST
| Q2 26 | $2.6B | — | ||
| Q1 26 | $2.6B | — | ||
| Q4 25 | $2.6B | $1.5B | ||
| Q3 25 | $2.6B | $1.5B | ||
| Q2 25 | $2.6B | $1.5B | ||
| Q1 25 | $2.6B | $1.5B | ||
| Q4 24 | $2.5B | $1.4B | ||
| Q3 24 | $2.5B | $1.4B |
总资产DLBLFST
| Q2 26 | $3.2B | — | ||
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $2.2B | ||
| Q3 25 | $3.2B | $2.1B | ||
| Q2 25 | $3.2B | $2.1B | ||
| Q1 25 | $3.2B | $2.1B | ||
| Q4 24 | $3.2B | $2.1B | ||
| Q3 24 | $3.1B | $2.1B |
负债/权益比DLBLFST
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.20× | ||
| Q3 24 | — | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $147.3M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | — | $46.6M |
| 自由现金流率自由现金流/营收 | — | 12.2% |
| 资本支出强度资本支出/营收 | — | 2.9% |
| 现金转化率经营现金流/净利润 | 1.55× | 4.93× |
| 过去12个月自由现金流最近4个季度 | — | $110.0M |
8季度趋势，按日历期对齐
经营现金流DLBLFST
| Q2 26 | $147.3M | — | ||
| Q1 26 | $54.8M | — | ||
| Q4 25 | $54.8M | $57.6M | ||
| Q3 25 | $472.2M | $27.3M | ||
| Q2 25 | $67.7M | $64.4M | ||
| Q1 25 | $174.9M | $-3.1M | ||
| Q4 24 | $106.8M | $62.3M | ||
| Q3 24 | $327.3M | $22.7M |
自由现金流DLBLFST
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $50.2M | $46.6M | ||
| Q3 25 | $435.9M | $17.0M | ||
| Q2 25 | $61.3M | $56.6M | ||
| Q1 25 | $168.0M | $-10.3M | ||
| Q4 24 | $100.0M | $56.0M | ||
| Q3 24 | $297.2M | $17.7M |
自由现金流率DLBLFST
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 14.5% | 12.2% | ||
| Q3 25 | 142.0% | 4.7% | ||
| Q2 25 | 19.4% | 16.4% | ||
| Q1 25 | 45.5% | -3.1% | ||
| Q4 24 | 28.0% | 17.2% | ||
| Q3 24 | 97.5% | 5.7% |
资本支出强度DLBLFST
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.3% | 2.9% | ||
| Q3 25 | 11.8% | 2.8% | ||
| Q2 25 | 2.0% | 2.2% | ||
| Q1 25 | 1.9% | 2.2% | ||
| Q4 24 | 1.9% | 1.9% | ||
| Q3 24 | 9.8% | 1.6% |
现金转化率DLBLFST
| Q2 26 | 1.55× | — | ||
| Q1 26 | 1.03× | — | ||
| Q4 25 | 1.03× | 4.93× | ||
| Q3 25 | 9.57× | 25.34× | ||
| Q2 25 | 1.47× | — | ||
| Q1 25 | 1.91× | -4.36× | ||
| Q4 24 | 1.57× | — | ||
| Q3 24 | 5.59× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DLB
| Licensing | $372.2M | 94% |
| Products and services | $23.4M | 6% |
LFST
暂无分部数据
